Basic Information
Neuronascent discovers and develops first-in-class small molecule therapies based on the science of neurogenesis, targeting depression, neurodegenerative diseases (including Alzheimer's and Parkinson's), and Down syndrome.
NeuroNascent, Inc.
Maryland,United States of America
less than 15 people
January 01, 2004
info@neuronascent.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios